Dev48
Language
  • About
  • Services
  • Industries
  • Technologies
  • Articles
  • Contacts
Book a call
    Home/Articles/Oxford nanopore marks a decade of sequencing in space
Dev48
info@dev48.org+375 29 320-40-96WhatsApp@isky_by

© 2026 · All rights reserved.

Oxford Nanopore marks a decade of sequencing in space

Source: Oxford Nanopore Technologies•November 12, 2026 at 04:08 PM

Oxford Nanopore marks a decade of sequencing in space

MinION, which sequenced DNA aboard the ISS in 2016, is now featured in the Smithsonian’s new At Home in Space exhibition and is set to travel to the Moon as part of the Artemis IV mission in 2028.

OXFORD, UK, Nov. 12, 2026 – Oxford Nanopore Technologies is marking ten years since its MinION device enabled NASA to perform the first DNA sequencing in space. The technology is now part of a new exhibition at the Smithsonian National Air and Space Museum in Washington, DC., and the story is set to continue to the Moon.

The crew of Artemis IV, planned for launch in 2028, will use MinION as part of their Microbiology of the Built Environment project, and it will also support microbial surveillance in the development of Moon Base, humanity’s first lunar outpost.

In August 2016, NASA astronaut Kate Rubins used a MinION aboard the International Space Station (ISS) to sequence DNA in space for the first time, demonstrating that nanopore sequencing could operate successfully in microgravity. Small enough to take into space and able to generate data in real time, the technology opened up the possibility of analysing biology where it happens, rather than depending entirely on laboratory work once samples reach Earth.

In the years since, NASA researchers have used nanopore sequencing to identify microbes aboard the ISS and explore its potential for microbial monitoring, crew health and future biological research. NASA’s recent astronaut recruitment video highlights nanopore sequencing as an example of the science awaiting future space explorers.

Today, MinION features in the Smithsonian’s new At Home in Space exhibition, which explores more than 50 years of learning how humans can live and work in space and how that experience is informing the next era of human exploration.

Francis Van Parys, Chief Executive Officer of Oxford Nanopore Technologies, commented: “Ten years ago, MinION proved that DNA could be sequenced in space. To see it in the Smithsonian today is quite a moment. We’re incredibly proud of what our teams and colleagues at NASA have achieved together, and even more excited about where the science could take us next.”

Sarah Wallace, Technical Lead, Microbiology at NASA Johnson Space Center, added: “Being able to sequence DNA in space opened up entirely new possibilities for biological research. A small, portable sequencer that can generate live data gives us the ability to study biology where it happens, rather than relying on samples being returned to Earth. That becomes increasingly important as we look towards longer and more distant missions.”

← All articles

What this article says

More in HealthTech & MedTech

All →
Inovalon To Acquire Intelligent Medication Management Company DrFirst
Inovalon

Inovalon To Acquire Intelligent Medication Management Company DrFirst

Sonova HY 2026/27 results: Raising full-year guidance after strong first half
Sonova

Sonova HY 2026/27 results: Raising full-year guidance after strong first half

Why BGM and CGM Readings are Sometimes Different
Dexcom

Why BGM and CGM Readings are Sometimes Different

Diligent Robotics Joins CHIME Foundation to Advance AI-Powered Automation in Healthcare
Diligent Robotics

Diligent Robotics Joins CHIME Foundation to Advance AI-Powered Automation in Healthcare

Billing Now Starts in the EHR
Elation Health

Billing Now Starts in the EHR

GE HealthCare announces intent to establish MAGNUS Neuro Alliance to unlock new possibilities in MRI for neuroscience
Ge Healthcare

GE HealthCare announces intent to establish MAGNUS Neuro Alliance to unlock new possibilities in MRI for neuroscience

More from Oxford Nanopore

mSCAPE: a national collaboration using metagenomics to protect public health
Oxford Nanopore

mSCAPE: a national collaboration using metagenomics to protect public health

Science Unlocked: publication picks from September 2026
Oxford Nanopore

Science Unlocked: publication picks from September 2026

Appointment of Chief Business Development Officer
Oxford Nanopore

Appointment of Chief Business Development Officer

RAPID answers for rare diseases
Oxford Nanopore

RAPID answers for rare diseases

Healthcare leaders expect genomics to become part of routine care within a decade
Oxford Nanopore

Healthcare leaders expect genomics to become part of routine care within a decade

Oxford Nanopore joins global rare disease network RISE to expand access to genomic testing
Oxford Nanopore

Oxford Nanopore joins global rare disease network RISE to expand access to genomic testing